Table of Contents - WOC 2012

WOC2012 Abstract Book
FP-RET-FR 122 (3)
Intravitreal Bevacizumab in Macular Edema of Central Retinal
Venous Occlusion
Deka Satyen (1) , Bhattacharjee Harsha (1) , Saibum Ronel (1) , Barman Manab
(1) (1)
, Das Shrutanjoy M
1. Sri Sankaradeva Nethralaya
Purpose: To study the effect of Intravitreal Bevacizumab in macular edema of
central retinal vein occlusion (CRVO).
Method: In this consecutive interventional case series of 25 patients with
macular edema secondary to CRVO were treated with intravitreal bevacizumab
(1.25 mg/0.05ml). Patients were followed up the next day after the injection,
then at 4 weeks and subsequently at 3 month intervals. Repeated injections
were given if OCT showed persistent macular edema. Results were analyzed
using statistical tests.
Results: Mean follow up period was 6 months (range 3-18 months). BCVA
improved in 20 (80%) and remained stable in 5 (20%) eyes. No cases of
visual deterioration. The mean foveal thickness was >600 µm at baseline that
reduced to